Biofrontera Stock (NASDAQ: BFRI) stock price, news, charts, stock research, profile.
Open | $1.150 |
Close | - |
Volume / Avg. | 3.316K / 769.734K |
Day Range | 1.110 - 1.150 |
52 Wk Range | 0.610 - 13.480 |
Market Cap | $5.853M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 5.29% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Biofrontera (NASDAQ: BFRI) through any online brokerage.
Other companies in Biofrontera’s space includes: Cingulate (NASDAQ:CING), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX), Universe Pharmaceuticals (NASDAQ:UPC) and Jaguar Health (NASDAQ:JAGX).
The latest price target for Biofrontera (NASDAQ: BFRI) was reported by Benchmark on Thursday, August 31, 2023. The analyst firm set a price target for 18.00 expecting BFRI to rise to within 12 months (a possible 1465.22% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Biofrontera (NASDAQ: BFRI) is $1.15 last updated March 27, 2024 at 7:59 PM EDT.
There are no upcoming dividends for Biofrontera.
Biofrontera’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Biofrontera.
Biofrontera is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.